Tamoxifen for the Prevention of Breast Cancer in High-Risk Women
NCT00002644
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
7154
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Tamoxifen Citrate 20Mg Tab
OTHER:
Placebo
Sponsor
Queen Mary University of London